Palatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025

10.02.25 22:00 Uhr

Werte in diesem Artikel

CRANBURY, N.J., Feb. 10, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fiscal year 2025 operating results on Thursday, February 13, 2025, before the open of the U.S. financial markets.

Palatin Technologies, Inc.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on February 13, 2025, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Audio Webcast



Q2 Fiscal Year 2025 Results Press Release                                     

02/13/2025 at 7:30 a.m. ET



Q2 Fiscal Year 2025 Conference Call-Live                                     

02/13/2025 at 11:00 a.m. ET

US Toll Free Dial-In Number:                                                     

1-888-506-0062

International Dial-In Number:                                                     

1-973-528-0011

Participant Access Code:                                                             

882092



Q2 Fiscal Year 2025 Conference Call-Replay                                 

02/13/2025-02/27/2025

US Toll Free Dial-In Number:                                                     

1-877-481-4010

International Dial-In Number:                                                     

1-919-882-2331

Participant Access Code:                                                             

52016

The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.

About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-second-quarter-fiscal-year-2025-results-teleconference-and-webcast-to-be-held-on-february-13-2025-302372745.html

SOURCE Palatin Technologies, Inc.

Ausgewählte Hebelprodukte auf Palatin Technologies

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Palatin Technologies

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Palatin Technologies Inc Registered Shs

Wer­bung